发明申请
US20100209962A1 Tetranor PGDM: A Biomarker of PGD2 Synthesis In Vivo
有权
Tetranor PGDM：PGD2 Synthesis In Vivo的生物标志物
- 专利标题： Tetranor PGDM: A Biomarker of PGD2 Synthesis In Vivo
- 专利标题（中）： Tetranor PGDM：PGD2 Synthesis In Vivo的生物标志物
-
申请号： US12680153申请日： 2008-09-29
-
公开(公告)号： US20100209962A1公开(公告)日： 2010-08-19
- 发明人: Garret A. FitzGerald , Wenliang Song , John A. Lawson
- 申请人： Garret A. FitzGerald , Wenliang Song , John A. Lawson
- 专利权人： THE TRUSTEES OF THE UNIVERSIT OF PENNSYLVANIA
- 当前专利权人： THE TRUSTEES OF THE UNIVERSIT OF PENNSYLVANIA
- 国际申请： PCT/US08/78141 WO 20080929
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; C07C59/353 ; C07K16/18
摘要：
The present invention relates to a prostaglandin D2 metabolite, derivatives thereof, compositions comprising the metabolite, and an antibody that specially binds to the metabolite. Methods of use are also provided.
公开/授权文献
- US08785682B2 Tetranor PGDM: a biomarker of PGD2 synthesis in vivo 公开/授权日：2014-07-22
信息查询
IPC分类:
